美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Columbia Research Enhanced Value ETF

34.13

+0.12390.36%

成交量：2.74万

成交额：93.26万

市值：3.48亿

市盈率：- -

高：34.17

开：34.17

低：34.03

收：34.00

52周最高：34.23

52周最低：27.24

股本：1,021.04万

流通股本：1,021.04万

量比：1.09

换手率：0.27%

股息：0.60

股息率：1.76%

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

美银一口气上调10只软件股目标价！Workday(WDAY.US)飙涨46%领衔，AI担忧退潮估值修复提速

澳大利亚储备银行：但当前政策的限制性程度已足以在合理时间框架内将通胀回落至目标水平。

【券商聚焦】国泰海通维持保险业“增持”评级《资产负债管理办法》支撑板块估值修复

【券商聚焦】交银国际维持先声药业（02096）买入评级指新品集中上市及全球化提速支撑估值修复

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/REVS"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"REVS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"REVS\",,,,,undefined,":{"symbol":"REVS","market":"US","secType":"STK","nameCN":"Columbia Research Enhanced Value ETF","latestPrice":34.1284,"timestamp":1787601600000,"preClose":34.0045,"halted":0,"volume":27357,"delay":0,"changeRate":0.0036436354011968714,"floatShares":10210364,"shares":10210364,"eps":0,"marketStatus":"盘前交易","change":0.1239,"latestTime":"08-25 08:51:48 EDT","open":34.17,"high":34.17,"low":34.03,"amount":932629.046349,"amplitude":0.004117,"askPrice":38.8,"askSize":100,"bidPrice":29.89,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787664600000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":34.1284,"sharesOutstanding":7400000,"nav":33.96295,"aum":348472229.56,"dividendRate":0.017601,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":34.11,"preClose":34.1284,"latestTime":"19:30 EDT","volume":10,"amount":341.284,"timestamp":1787614206860,"change":-0.0184,"changeRate":-0.000539,"amplitude":0},"volumeRatio":1.0857762072594017},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"REVS\",,,,,undefined,":{"symbol":"REVS","floatShares":10210364,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.0857762072594017,"shares":10210364,"dividePrice":0.6007,"high":34.17,"amplitude":0.004117,"preClose":34.0045,"low":34.03,"week52Low":27.2428,"pbRate":"--","week52High":34.2294,"institutionHeld":0,"latestPrice":34.1284,"eps":0,"divideRate":0.017601,"volume":27357,"delay":0,"ttmEps":0,"open":34.17,"prevYearClose":28.283,"prevWeekClose":34.0045,"prevMonthClose":33.2,"prevQuarterClose":31.44,"fiveDayClose":33.7438,"twentyDayClose":33.04,"sixtyDayClose":31.5159},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/REVS\",params:#limit:5,,,undefined,":[{"date":"2025-12-18","symbol":"REVS","amount":0.60215,"announcedDate":"2025-12-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-18","defaultRemindTime":1766068200000,"name":"Columbia Research Enhanced Value ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-18","currency":"USD","dateTimestamp":1766034000000,"payDate":"2025-12-26"},{"date":"2024-12-18","symbol":"REVS","amount":0.46667,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-18","defaultRemindTime":1734532200000,"name":"Columbia Research Enhanced Value ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-18","currency":"USD","dateTimestamp":1734498000000,"payDate":"2024-12-26"},{"date":"2023-12-18","symbol":"REVS","amount":0.53855,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"Columbia Research Enhanced Value ETF","recordDate":"2023-12-26","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-26"},{"market":"US","date":"2022-12-19","symbol":"REVS","amount":0.48105,"defaultRemindTime":1671460200000,"name":"Columbia Research Enhanced Value ETF","recordDate":"2022-12-27","payableDate":"2022-12-20","currency":"USD","type":"dividend","dateTimestamp":1671426000000},{"market":"US","date":"2021-12-20","symbol":"REVS","amount":0.12796,"defaultRemindTime":1640010600000,"name":"Columbia Research Enhanced Value ETF","recordDate":"2021-12-28","payableDate":"2021-12-21","currency":"USD","type":"dividend","dateTimestamp":1639976400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"REVS\",market:\"US\",,,undefined,":[{"executeDate":"2019-12-20","recordDate":"2019-12-23","paymentDate":"2019-12-26","value":0.00358,"currency":"USD"},{"executeDate":"2020-12-18","recordDate":"2020-12-21","paymentDate":"2020-12-28","value":0.49625,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-28","value":0.12796,"currency":"USD"},{"executeDate":"2022-12-19","recordDate":"2022-12-20","paymentDate":"2022-12-27","value":0.48105,"currency":"USD"},{"executeDate":"2023-12-18","recordDate":"2023-12-19","paymentDate":"2023-12-26","value":0.53855,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"REVS\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"REVS\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662878182","title":"美银一口气上调10只软件股目标价！Workday(WDAY.US)飙涨46%领衔，AI担忧退潮估值修复提速","url":"https://stock-news.laohu8.com/highlight/detail?id=2662878182","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662878182?lang=zh_cn&edition=fundamental","pubTime":"2026-08-25 14:53","pubTimestamp":1787640833,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AGIX","LCO","IGM","LU0719512351.SGD","WDAY","CHAT","LU0082616367.USD","LU1935043536.SGD","REVS","VTHR","LU1823568750.SGD","BK4581","BK4613","LU1046421795.USD","LU2265009873.SGD","AIPO","IGV","CZA","LU1989763005.USD","LU1935042991.SGD","LU2517655291.USD","LU2517655028.SGD","BK4548","ARTY","BK4023","BK4585","LU1804176565.USD","LU2517655374.HKD","BK4588","QTOC","IE0004445239.USD","NIFE","LU0314104364.USD","LU1691799644.USD","IE0009356076.USD","BK4528","LU1989773731.SGD","LU1235294995.USD","IE00B5949003.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662207421","title":"澳大利亚储备银行：但当前政策的限制性程度已足以在合理时间框架内将通胀回落至目标水平。","url":"https://stock-news.laohu8.com/highlight/detail?id=2662207421","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662207421?lang=zh_cn&edition=fundamental","pubTime":"2026-08-25 09:31","pubTimestamp":1787621493,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MAVF","DSTL","MOAT","LQ","BGDV","RSP","HFSI","AOM","BLCV","LVHD","NDOW","RPHS","AGOX","RWVG","SQLV","OBND","MCOW","OCIO","SPDG","FOVL","SMRI","EZRO","BINC","GVUS","FVAL","MFUL","EASY","PY","QARP","BBHM","WBND","ABEQ","DVY","ULVM","VLU","PJFV","DUKZ","THRV","DURA","QPX","EUCG","REVS","HDV","USDX","RDVY","CAMX","XFLX","OACP","CGCV","DFLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662207403","title":"【券商聚焦】国泰海通维持保险业“增持”评级 《资产负债管理办法》支撑板块估值修复","url":"https://stock-news.laohu8.com/highlight/detail?id=2662207403","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662207403?lang=zh_cn&edition=fundamental","pubTime":"2026-08-25 09:29","pubTimestamp":1787621380,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国泰海通证券研究指，8月21日，金监总局发布《保险公司资产负债管理办法》（下称《办法》），于27年1月1日实施，不达标险企设置三年过渡期。该机构认为，当前保险股PEV估值仍反映较为悲观的投资收益率预期，核心原因在于资负错配导致ROE的不确定性较高。该机构预计《资产负债管理办法》将由治理体系到经营层面深刻影响险企保险业务发展及资产配置行为，有效的资产负债匹配管理利好保险公司的盈利稳定性提升，从而对估值修复构成有效支撑，维持“增持”评级。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/ZDNhNDUwNDVmY2U2MTcxMzU2NTcyMzcyOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ZDNhNDUwNDVmY2U2MTcxMzU2NTcyMzcyOQ==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1989229","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GABF","REVS","02611","KCE","NIFE","FXO","LCO","CZA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662207163","title":"【券商聚焦】交银国际维持先声药业（02096）买入评级 指新品集中上市及全球化提速支撑估值修复","url":"https://stock-news.laohu8.com/highlight/detail?id=2662207163","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662207163?lang=zh_cn&edition=fundamental","pubTime":"2026-08-25 09:23","pubTimestamp":1787620993,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际研报指，先声药业 1H26收入和经调整净利润分别增长27.8%/48.7%，其中创新药收入+34%至39亿元，对总收入的贡献升至85%。3）自免线艾得辛虽未中标集采，但公司目标维持约50%市场份额。IL-4R和外用JAK1/JAK2凝胶预计2027 年商业化，缓解艾得辛竞争压力。公司维持全年收入100亿元的指引，经调整净利润指引从16亿上调至18亿元。该机构将DCF模型向前滚动至2027 年，得到最新目标价20港元。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250109/NjdhYmE3ZDczMTc4NjgyMDYzMDA3NjI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NjdhYmE3ZDczMTc4NjgyMDYzMDA3NjI=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1989224","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096","REVS","NIFE","KCE","IPOS","LCO","CZA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":48,"pageCount":1,"totalSize":190,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/REVS\",params:#limit:6,delay:false,,,undefined,":[]}}